{"id":"W4406701803","doi":"10.1016/j.pharmr.2025.100042","title":"Cyclic nucleotide phosphodiesterases as drug targets","year":2025,"lang":"en","type":"review","venue":"Pharmacological Reviews","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"National Eye Institute; National Institute on Aging; Helse Sør-Øst RHF; Canadian Institutes of Health Research; Manchester Biomedical Research Centre; NIHR Oxford Biomedical Research Centre; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Agence Nationale de la Recherche; National Multiple Sclerosis Society; Deutsche Forschungsgemeinschaft; National Cancer Institute; National Institute on Alcohol Abuse and Alcoholism; British Heart Foundation; Natural Sciences and Engineering Research Council of Canada; Health~Holland; National Institutes of Health; Smart Family Foundation; Novartis; Kreftforeningen; Foundation for Cardiovascular Research","keywords":"Phosphodiesterase; Nucleotide; Drug; Cyclic nucleotide; Cyclic nucleotide phosphodiesterase; Chemistry; Pharmacology; Computational biology; Biochemistry; Cell biology; Biology; Enzyme; Gene","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005553962,0.0007583933,0.001984467,0.0001027937,0.0001913623,0.00006068961,0.0005368193,0.0004127789,0.001010411],"category_scores_gemma":[0.0006061149,0.0005081881,0.001282255,0.0003192549,0.0001265085,0.000007551621,0.0003941221,0.0004202779,0.0008837507],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007402852,"about_ca_system_score_gemma":0.0002397864,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005484797,"about_ca_topic_score_gemma":0.000003907553,"domain_scores_codex":[0.9964873,0.0007903643,0.001111389,0.0009622512,0.0001834308,0.000465269],"domain_scores_gemma":[0.9984933,0.0001457449,0.0005667963,0.0004907663,0.00007023339,0.0002331694],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002947442,0.0001355228,0.000002208017,0.005943799,0.0001742642,0.00001397081,0.000004996534,9.410169e-7,0.0002962892,0.00003625832,0.1618012,0.831561],"study_design_scores_gemma":[0.0002659184,0.00008462078,0.000001911038,0.003668356,0.0009869956,0.00002335173,0.000002138914,8.498233e-7,0.0006960855,0.00003055442,0.993707,0.0005322219],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002570316,0.9908425,0.00007103416,0.00007555879,0.001430803,0.002136291,0.00004952919,0.00006070713,0.005307856],"genre_scores_gemma":[0.00001108681,0.9760525,0.0001982849,0.002178265,0.0005884542,0.0008393938,0.0008501762,0.00004200248,0.01923981],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8319057,"threshold_uncertainty_score":0.9999028,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04384731252438048,"score_gpt":0.3880629043917895,"score_spread":0.344215591867409,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}